North America Will Remain the Most Attractive Market for Vitamins and Derivative

Posted by Arslan on February 7th, 2019

According to a new report published by Fact.MR, the vitamins and derivatives market is expected to surpass 165,000 tons by the end of 2026 in terms of volume. During the forecast period (2017-2026), the market is projected to exhibit a CAGR of 3.5% in term of value. Rising health awareness among consumers, increasing demand for healthy and functional food, expanding geriatric population are some of important factors likely to influence the global consumption of vitamins and derivatives during the review period. Moreover, increased demand for products with higher nutritional content is expected to reflect favorably on the market. In has been observed that, use of vitamin supplements has grown notably in the countries such as Brazil, China, Philippines and India, which has propelled the market further.

The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of global vitamins and derivatives market. Key segments that define growth of the global vitamins and derivatives market include product type, target group, end use Industries, form and region. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included.

North America to Remain the Most Attractive Market for Vitamins and Derivatives

The market in North America is expected to remain highly lucrative for vitamins and derivatives throughout the assessment period. The region’s market is projected to exhibit a steady CAGR between 2017 and 2026. Use of vitamins and derivative supplement is significantly high in the region. Americans are increasingly inclining towards such products to ensure a balanced diet.

Vitamin B a Leading Product Type

Use of vitamin B is significantly high across the globe. Vitamin B finds application in manufacturing of various function food, cosmetics, and dietary supplements. The global sales of vitamin B currently represents for more than one-fourth share of the market in terms of revenue. Towards the end of 2026, nearly US$ 7,355.2 Mn worth vitamin B is expected to be sold worldwide.

 Browse Full report with TOC 

https://www.factmr.com/report/380/vitamins-derivatives-market

On the basis of end use industry, the food and beverage segment is likely to retain its top position over 2026. By the end of 2026, this segment is estimated to surpass a market valuation of US$ 6,900 Mn, reflecting an above-average CAGR.

Global Market for Vitamins and Derivatives: Competition Tracking

Fact.MR in its report has profiled key market players, which include Herbalife, ADM, Abott Laboratories, Glanbia, Pfizer, Lonza Group Ltd, Sanofi, BoehringerIngelheim Consumer Health Care, CSPC Pharmaceutical Group Limited, Adisseo France S.A.S, Amway, Glanbia PLC, DSM, GlaxoSmithKline, Bayer, Jubilant Life Sciences Limited, Atrium Innovations, Inc., Schiff Nutrition International, Inc, Fermenta Biotech Ltd., and Bactolac Pharmaceutical, Inc